Brief: Lisata Therapeutics Announces First Patient Treated In Phase 2A Trial Of Lsta1
17/01/2024 13:24
Jan 17 (Reuters) - Lisata Therapeutics Inc LSTA.O :
* LISATA THERAPEUTICS ANNOUNCES FIRST PATIENT TREATED IN THE
PHASE
2A TRIAL OF LSTA1 IN PATIENTS WITH GLIOBLASTOMA MULTIFORME
Source text for Eikon: ID:nGNXKYmn2
Further company coverage: LSTA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lisata Therapeutics
See all newsBrief: Lisata Therapeutics Appoints Jeff Farrow To Board Of Directors
Brief: Lisata Therapeutics Announces New Method Of Use Patent Granted For Certepetide In The Treatment Of Pancreatic Cancer And Other Solid Tumors
NASDAQ RESUMED AT 09:55 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:55 AM
U.S. STOCKS ON THE MOVE -Expeditors International, Waters, Ameresco